← Back to Clinical Trials
Recruiting NCT06969872

NCT06969872 Effects of Probiotics on Symptoms of Constipation in Adults With Functional Constipation

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06969872
Status Recruiting
Phase
Sponsor Chung Shan Medical University
Condition Functional Constipation (FC)
Study Type INTERVENTIONAL
Enrollment 165 participants
Start Date 2024-12-27
Primary Completion 2026-09-30

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 75 Years
Study Type INTERVENTIONAL
Interventions
PlaceboProbiotics (ABKefir)

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 165 participants in total. It began in 2024-12-27 with a primary completion date of 2026-09-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The purpose of this study was to evaluate the efficacy of 1 capsules of ABKefir per day on symptoms of constipation in subjects with functional constipation by clinical trial.

Eligibility Criteria

Inclusion Criteria: * male or female * aged 18-75 years old * fulfill Rome IV criteria for functional constipation * have not participated in similar research in the past three months Exclusion Criteria: * Personal or family history of colon cancer, celiac disease, and inflammatory bowel disease * Irritable bowel syndrome diagnosed during colonoscopy * Those who are pregnant recently (including men and women), or are pregnant or breastfeeding women. * Taking antidepressants, anti-anxiety drugs and other psychotropic drugs. * Long-term medication is required to improve constipation * Those diagnosed with myocardial infarction, cerebral infarction, malignant tumor and/or other serious diseases are not suitable for participating in the study. * Allergic symptoms to probiotics or any ingredients * Having a history of serious mental illness * Drug-related crimes or alcohol problems * Have recently traveled to areas where parasitic diseases are prevalent.

Contact & Investigator

Central Contact

Chin-Lin Hsu, Professor

✉ clhsu@csmu.edu.tw

📞 04-24730022

Principal Investigator

Hsin-Chi Pan, MS student

PRINCIPAL INVESTIGATOR

Chung Shan Medical University

Frequently Asked Questions

Who can join the NCT06969872 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 75 Years, studying Functional Constipation (FC). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06969872 currently recruiting?

Yes, NCT06969872 is actively recruiting participants. Contact the research team at clhsu@csmu.edu.tw for enrollment information.

Where is the NCT06969872 trial being conducted?

This trial is being conducted at Taichung, Taiwan.

Who is sponsoring the NCT06969872 clinical trial?

NCT06969872 is sponsored by Chung Shan Medical University. The principal investigator is Hsin-Chi Pan, MS student at Chung Shan Medical University. The trial plans to enroll 165 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology